• Outset Medical Inc OM.OQ reported a quarterly adjusted loss of 39 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -71 cents. The mean expectation of seven analysts for the quarter was for a loss of 42 cents per share. Wall Street expected results to range from -46 cents to -37 cents per share.

• Revenue fell 5.6% to $28.67 million from a year ago; analysts expected $26.91 million.

• Outset Medical Inc's reported EPS for the quarter was a loss of 55 cents​.

• The company reported a quarterly loss of $27.94 million.

• Outset Medical Inc shares had fallen by 7.4% this quarter and lost 88.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Outset Medical Inc is 3.50

This summary was machine generated from LSEG data November 7 at 04:40 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)